Surveillance for Onchocerciasis-Associated Epilepsy and OV16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening

Surveillance for Onchocerciasis-Associated Epilepsy and OV16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening

To eliminate onchocerciasis-associated morbidity, it is important to identify areas where there is still high ongoing <i>Onchocerca volvulus</i> transmission. Between 2015 and 2021, door-to-door surveys were conducted in onchocerciasis-endemic villages in Cameroon, the Democratic Republi...

Celý popis

Podrobná bibliografie
Hlavní autoři: Alfred Dusabimana, Joseph Nelson Siewe Fodjo, Michel Mandro Ndahura, Bruno P. Mmbando, Stephen Raimon Jada, Annelies Boven, Eric De Smet, Tony Ukety, Alfred K. Njamnshi, Anne Laudisoit, Steven Abrams, Robert Colebunders
Médium: Článek
Jazyk:English
Vydáno: MDPI AG 2022-02-01
Edice:Pathogens
Témata:
onchocerciasis
onchocerciasis-associated epilepsy
epilepsy prevalence
incidence
ivermectin
OV16 antibodies
On-line přístup:https://www.mdpi.com/2076-0817/11/3/281

Podobné jednotky

Podobné jednotky